NEUTROPHIL - LYMPHOCYTE RATIO AS AN ANTICIPATORY FACTOR IN THE PROGNOSIS OF MORTALITY AND SEVERITY IN COVID-19 PATIENTS
Al-Sharwey, H., Helmy, M., Mostafa, K., Aiad, K. (2023). NEUTROPHIL - LYMPHOCYTE RATIO AS AN ANTICIPATORY FACTOR IN THE PROGNOSIS OF MORTALITY AND SEVERITY IN COVID-19 PATIENTS. EKB Journal Management System, 5(1), 18-19. doi: 10.21608/alexpo.2023.192451.1554
Hany Mohamed Ameen Al-Sharwey; Mona Wagdy Helmy; Khaled Salah Mostafa; Khalid Aiad. "NEUTROPHIL - LYMPHOCYTE RATIO AS AN ANTICIPATORY FACTOR IN THE PROGNOSIS OF MORTALITY AND SEVERITY IN COVID-19 PATIENTS". EKB Journal Management System, 5, 1, 2023, 18-19. doi: 10.21608/alexpo.2023.192451.1554
Al-Sharwey, H., Helmy, M., Mostafa, K., Aiad, K. (2023). 'NEUTROPHIL - LYMPHOCYTE RATIO AS AN ANTICIPATORY FACTOR IN THE PROGNOSIS OF MORTALITY AND SEVERITY IN COVID-19 PATIENTS', EKB Journal Management System, 5(1), pp. 18-19. doi: 10.21608/alexpo.2023.192451.1554
Al-Sharwey, H., Helmy, M., Mostafa, K., Aiad, K. NEUTROPHIL - LYMPHOCYTE RATIO AS AN ANTICIPATORY FACTOR IN THE PROGNOSIS OF MORTALITY AND SEVERITY IN COVID-19 PATIENTS. EKB Journal Management System, 2023; 5(1): 18-19. doi: 10.21608/alexpo.2023.192451.1554

NEUTROPHIL - LYMPHOCYTE RATIO AS AN ANTICIPATORY FACTOR IN THE PROGNOSIS OF MORTALITY AND SEVERITY IN COVID-19 PATIENTS

ALEXMED ePosters
Article 1, Volume 5, Issue 1, January 2023, Page 18-19  XML
Document Type: Preliminary preprint short reports of original research
DOI: 10.21608/alexpo.2023.192451.1554
View on SCiNiTO View on SCiNiTO
Authors
Hany Mohamed Ameen Al-Sharwey1; Mona Wagdy Helmy2; Khaled Salah Mostafa3; Khalid Aiad email 4
1Department of Chest Diseases, Chest Diseases, Faculty of Medicine, Alexandria University.
2Department of Clinical and Chemical Pathology, Faculty of Medicine Alexandria University
3Department of emergency medicine,faculty of medicine Alexandria university,Egypt
4Department of Emergency Medicine, Emergency Medicine, Faculty of Medicine, Alexandria University.
Abstract
The national Institute of fitness of China in 2019 informed the world health organization (WHO) to several cases of pneumonia in Wuhan, China. Several cases have been infected with Coronavirus, and the virus was named by WHO as Coronavirus disease 2019 (Covid-19). At the middle of January 2020, around seven thousand cases and twelve thousand suspected cases were reported in China, and 80 confirmed instances had been observed in about twenty different international locations.WHO declared that SARS-CoV-2 is an epidemic condition and a public outbreak.
Different laboratory investigations have been proposed for the early detection, and identification of patients who were affected with SARS-CoV-2 virus, including decrease lymphocytic count, prolonged prothrombin time. Different cases have shown to have an increase of inflammatory markers, including: C-reactive protein, creatinine kinase, and prolactin levels.
Aim of the Work
The primary aim of this study was to evaluate Predictive values of neutrophil-to-lymphocyte ratio on disease severity and mortality in COVID-19 PCR positive patients. The secondary aim of this study is looking for various parameters related to worsening outcomes.
Keywords
SARS-CoV-2 virus; NEUTROPHIL - LYMPHOCYTE RATIO; prognosis
Supplementary Files
Statistics
Article View: 56